Australia markets closed

Samsung Biologics Co.,Ltd. (207940.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
787,000.00+6,000.00 (+0.77%)
At close: 03:30PM KST
Currency in KRW
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts781010
Avg. Estimate2,823.263,371.3213,961.917,230.3
Low estimate2,2732,972.2612,56515,106
High estimate4,5194,21016,21719,788.6
Year ago EPS1,9922,59713,29013,961.9
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts54924
Avg. Estimate946.9M818.85M3.82B4.78B
Low estimate698M694.6M3.27B3.91B
High estimate979.7M962M4.63B5.24B
Year ago sales590.99M637.17M2.94B3.82B
Sales growth (year/est)60.20%28.50%30.10%25.10%
Earnings history31/03/202330/06/202330/09/202331/12/2023
Est. EPS2,128.632,485.973,220.43,296.4
Actual EPS1,9922,5973,3774,084.12
Difference-136.63111.03156.6787.72
Surprise %-6.40%4.50%4.90%23.90%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate2,823.263,371.3213,961.917,230.3
7 days ago2,823.263,363.6913,460.216,084.8
30 days ago2,904.643,411.4213,827.817,100.1
60 days ago3,090.183,362.0613,406.216,216.1
90 days ago3,090.183,362.0614,139.418,055.8
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A1N/AN/A
Up last 30 days1211
Down last 7 daysN/AN/AN/AN/A
Down last 30 days11N/AN/A
Growth estimates207940.KSIndustrySector(s)S&P 500
Current qtr.41.70%N/AN/AN/A
Next qtr.29.80%N/AN/AN/A
Current year5.10%N/AN/AN/A
Next year23.40%N/AN/AN/A
Next 5 years (per annum)24.28%N/AN/AN/A
Past 5 years (per annum)22.88%N/AN/AN/A